Norovirus: The World's Most Contagious Virus & The Race For The First Antiviral - James Sapirstein, CEO and Dr. Sam Lee, Ph.D., President and Chief Scientific Officer - Cocrystal Pharma

Episode notes

Send us Fan Mail Every year, nearly 700 million people around the world are infected by norovirus. Most people know it as a miserable few days of vomiting and diarrhea - but for transplant patients, cancer patients, and other immunocompromised individuals, it can become a chronic and potentially life-threatening infection. And despite decades of research, we still have no approved antiviral treatment. Today we're exploring the science behind the race to change that. James Sapirstein is Chief Executive Officer of Cocrystal Pharma ( ) and one of the biotechnology industry's most experienced commercialization executives. Throughout a career spanning more than four decades, James has participated in or led an extraordinary twenty-three pharmaceutical product launches while building and leading multiple biotechnology companies. He has served as CEO of Cocrystal Pharma, Contravir Pharmaceuticals, Tobira Therapeutics, First Wave BioPharma, and several other innovative life science organizations.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• Michelle Gill: AI-Assisted Drug Discovery, NVIDIA, Biofoundation Models, Creating Applied Research Teams | Learning from Machine Learning #8Learning from Machine Learning · on Drug Discovery88 / 100
• This Just In Radio: AI in Action with Tony Nunes of AMDThis Just In Radio Show · on Drug Discovery64 / 100
• Decoding AQ with Ross Thornley Feat. Lisa Hammond - Chief Human Resources Officer at VeradigmDECODING AQ · on Drug Discovery64 / 100
• Could This Be the First Parkinson's Disease Modifier?CareTalk: Healthcare. Unfiltered. · on Drug Discovery
• Why AI Isn't Ready to Make MedicinesTechSurge: Deep Tech Podcast · on Drug Discovery

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• The Blood Test That Could Change Cancer Treatment Forever | Eric Matthews - General Manager, Biopharma, Natera65 / 100
• How Female Biology Shapes Skin Disease Across a Lifetime | Dr. Doral Fredericks, PharmD, MBA - Vice President and Head of Global Medical Affairs and Outcomes Research, Organon56 / 100
• 55 Years Without a Diagnosis | Can AI Solve The Undiagnosed Condition Blind Spot? | Haresh Patel - Founder and CEO, Sanare Health AI70 / 100
• Inside the Global Biotech Ecosystem - Where Innovation Goes Next | Sara Jane Demy - Founder and CEO, Demy-Colton